pharma · Fibromyalgia · Primary Fibromyalgia · TNXP
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals is a pharma organization headquartered in Berkeley Heights, USA. It trades on NYSE under ticker TNXP. Primary therapeutic focus areas include Fibromyalgia, Primary Fibromyalgia, PTSD, Acute Stress R
200 Connell Dr, Berkeley Heights, New Jersey 07922, US HQ
2007 Founded
154 Employees
Public company Type
TNXP · NYSE Ticker
Company details
- Status
- Public
- HQ
- 200 Connell Dr, Berkeley Heights, New Jersey 07922, US
- Founded
- 2007
- Employees
- 154
- Programs
- 30
- Drugs
- 10
- Patents
- 86
Intranasal Oxytocin (IN-OXT)
Phase 1 · small molecule · Vasopressin Deficiency
Intranasal Oxytocin (IN-OXT) for Vasopressin Deficiency is a Phase 1 program (small_molecule) at Tonix Pharmaceuticals Holding with 1 ClinicalTrials.gov record(s).
Internal code 2020P003071
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Tonix Pharmaceuticals Holding
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Vasopressin Deficiency
- Status
- active
- Trials
- 1